Latest news
Loading news…
Lyell Immunopharma
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. South San Francisco, California, United States Founded 2018 251-500 employees For Profit
Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Investments
6
2 exits
Monthly Visits
Available in Pro Contacts
258
Ticker
LYEL
NASDAQ
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- LYEL
- Exchange
- NASDAQ
- IPO date
- Jun 16, 2021
- Raised at IPO
- $425M
- Valuation at IPO
- $4B
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 44
- IT spend
- $781.00
Investor Activity
- Investments
- 6
- Lead investments
- 2
- Portfolio orgs
- 5
- Diversity investments
- 3
- Exits
- 2
- Exits via IPO
- 2
Company Info
- Founded
- 2018
- Employees
- 251-500
- Operating status
- Active
- Company type
- For Profit
- Org types
- company, investor
- Founders
- 2
- News articles
- 127
- HQ
- South San Francisco, California, United States
- Region
- San Francisco Bay Area, West Coast, Western US
- Exit date
- Jun 16, 2021
Signals & Scores
- Heat score
- High
- Growth score
- High
- Trend (7d)
- 1.4
- Trend (30d)
- -0.7
- Trend (90d)
- -0.5
- Last leadership hire
- Mar 9, 2026
- Last layoff mention
- May 13, 2025
Investments by Lyell Immunopharma
Loading columns…
0 of 0Show
Page 1 / 1
Acquisitions by Lyell Immunopharma
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Lyell Immunopharma
President and Chief Executive Officer
Chief Business Officer and Principal Financial Officer
Senior Director of Research
Chief Scientific Officer
Principal Accounting Officer
VP Finance
Chief Information Officer
Senior Director, IP
Chief Legal Officer
258
professional contacts at Lyell Immunopharma
Contact execs at Lyell Immunopharma →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Lyell Immunopharma
Loading news…
FAQs about Lyell Immunopharma
People who checked this page also checked these
Sectors Lyell Immunopharma invests & acquires in
Browse the full Acquirezy directory.